Much of the public distrust stems from false information around messenger RNA (mRNA) vaccines for COVID-19, even though they ...

While Moderna isn’t looking to replace classical computing with quantum entirely, the company is interested in building a “quantum-enabled biotechnology pipeline.” In conjunction with IBM, the ...

How does a cell know when it’s been damaged? A molecular alarm, set off by mutated RNA and colliding ribosomes, signals ...

As the Q1 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the ...

The deal, announced on June 30, will advance a subsect of research into new autoimmune treatments that began at Penn.

Because they rely on hosts for a majority of functions, viruses aren’t considered alive. But entities like this one ...

The biotechnology company’s messenger RNA flu vaccine candidate showed positive results in a late-stage trial.

Study reveals how cells regulate repair protein production to prevent DNA damage over-repair or under-repair, aiding cell ...

The elephant vaccine closely resembles other mRNA vaccines made for humans. mRNA packed in lipid nanoparticles carries ...

Moderna is expected to announce its second-quarter results in the upcoming month, and analysts expect a slight reduction in ...

Cartesian's mRNA-based cell therapy offers a novel, outpatient approach for autoimmune diseases. Promising results, but Phase ...

In the vast and often unseen world of microscopic life, a recent discovery may force scientists to rethink what it means to ...